Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma

BACKGROUND: Previous trials have suggested that elderly patients with non‐small‐cell lung cancer (NSCLC) could benefit from nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel). Real‐world data on the elderly Chinese population are lacking. This study aimed to analyze the effectiveness and tolerab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuhang, Liang, Qiuping, Chi, Yujia, Zhuo, Minglei, An, Tongtong, Duan, Jianchun, Wang, Zhijie, Wang, Yuyan, Zhong, Jia, Yang, Xue, Chen, Hanxiao, Wang, Jie, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180581/
https://www.ncbi.nlm.nih.gov/pubmed/32162417
http://dx.doi.org/10.1111/1759-7714.13356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180581/
https://www.ncbi.nlm.nih.gov/pubmed/32162417
http://dx.doi.org/10.1111/1759-7714.13356

Ejemplares similares